Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Filament Health Corp. FLHLF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
29/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Filament Health Corp. (FLHLF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 28/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $616,678, +206.8%/yr average growth. Net income is $5M (loss), growing at -1.2%/yr. Net profit margin is -806% (negative). Gross margin is 100% (+0 pp trend).

Balance sheet: total debt is $264,502 against $2M equity (Debt-to-Equity (D/E) ratio 0.15, conservative). Current ratio is 0.44 (tight liquidity). Debt-to-assets is 7.8%. Total assets: $3M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 46/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

FLHLF SharesGrow Score Overview

37/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 46/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — FLHLF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
FLHLF: +206.8%/yr revenue is, -1.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet FLHLF: Debt-to-Equity (D/E) ratio 0.15 (conservative), Current ratio is 0.44 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
46/100
FLHLF: Gross margin is 100% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 46/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
FLHLF: Net profit margin is -806%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.0001-0.0248
Volume30K
Avg Volume (30D)17.4K
Market Cap$26.18K
Beta (1Y)0.72
Share Statistics
EPS (TTM)-0.02
Shares Outstanding$237.38M
IPO Date2021-09-03
Employees13
CEOBenjamin Lightburn
Financial Highlights & Ratios
Revenue (TTM)$616.68K
Gross Profit$616.68K
EBITDA$-4.52M
Net Income$-4.97M
Operating Income$-3.67M
Total Cash$391.24K
Total Debt$264.5K
Net Debt$-126.74K
Total Assets$3.41M
Price / Earnings (P/E)-0
Price / Sales (P/S)0.04
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA31685W1068

Price Chart

Track all markets on TradingView
FLHLF
Filament Health Corp. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.02

People Also View

APNHF
APNHF
Aspen Pharmacare Holdings Limited
$8.69
+0.00%
 ATHJF
ATHJF
Antisense Therapeutics Limited
$0.01
-76.00%
 MGCLF
MGCLF
MGC Pharmaceuticals Limited
$0.27
+2.88%
 BCBCF
BCBCF
The BC Bud Corporation
$0.04
-3.31%
 CBDNF
CBDNF
CBD Global Sciences Inc.
$0.04
-2.67%
 ANTCF
ANTCF
Aion Therapeutic Inc.
$0.00
+0.00%
 SFWJ
SFWJ
Software Effective Solutions Corp.
$0.00
+0.00%
 CBDY
CBDY
Target Group Inc.
$0.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message